G CSF (CSF3) (NM_001178147) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC229626L4V
- LentiORF®
Lenti ORF particles, CSF3 (mGFP-tagged) - Human colony stimulating factor 3 (granulocyte) (CSF3), transcript variant 4, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,360.00
Product images
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | G CSF (CSF3) (NM_001178147) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | C17orf33; CSF3OS; GCSF |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_001178147 |
ORF Size | 504 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC229626).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_001178147.1 |
RefSeq ORF | 507 bp |
Locus ID | 1440 |
Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Secreted Protein |
Protein Pathways | Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Jak-STAT signaling pathway |
MW | 18.6 kDa |
Gene Summary | This gene encodes a member of the IL-6 superfamily of cytokines. The encoded cytokine controls the production, differentiation, and function of granulocytes. Granulocytes are a type of white blood cell that are part of the innate immune response. A modified form of this protein is commonly administered to manage chemotherapy-induced neutropenia. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2020] |
Documents
Product Manuals |
FAQs |
SDS |